Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR‑665 and regulating LASP1

Xu,Xiabing; Zhao,Yadong; Duan,Gang; Du,Bo

doi:10.3892/etm.2021.10777

Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR‑665 and regulating LASP1

Authors:
- Xiabing Xu
- Yadong Zhao
- Gang Duan
- Bo Du
View Affiliations

Affiliations: Department of Ophthalmology, No. 215 Hospital of Shaanxi Nuclear Industry, Xianyang, Shaanxi 712000, P.R. China
Published online on: September 22, 2021 https://doi.org/10.3892/etm.2021.10777
Article Number: 1342

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) can function as onco‑lncRNAs in several types of human cancer, including retinoblastoma (Rb). The present study investigated the potential role and regulatory mechanism of the lncRNA myocardial infarction‑associated transcript (MIAT) in Rb. To do so, the expression levels of MIAT, microRNA (miR)‑665, and LIM and SH3 protein 1 (LASP1) in Rb tissues from patients or Rb cells were analysed using reverse transcription quantitative PCR. The interactions between miR‑665 and MIAT/LASP1 were confirmed by the dual‑luciferase reporter assay. MTT, Transwell (to assess migration and invasion) and western blotting assays were used to explore the functions of the MIAT/miR‑665/LASP1 axis on Rb progression in vitro. The results of the present study indicated that MIAT targeted miR‑665. In Rb tissues and cell lines, high expression of MIAT was observed, whereas miR‑665 was downregulated in Rb tissues. Furthermore, the proliferation and migratory and invasive abilities of Rb Y79 and HXO‑RB44 cells were decreased following MIAT downregulation or miR‑665 overexpression. In addition, LASP1 was identified as a target gene of miR‑665. Both the decreased expression of miR‑665 and the elevated expression of LASP1 reversed the suppressive effects of MIAT knockdown on the proliferation and migratory and invasive abilities of Y79 cells. Furthermore, MIAT silencing attenuated the development of Rb by regulating the miR‑665/LASP1 axis. Taken together, these findings suggested that MIAT may be considered as a possible therapeutic target for Rb.

View Figures

View References

1	Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, Weber K, Correa G, Paco S, Vila-Ubach M, et al: Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Sci Transl Med. 11(11)2019.PubMed/NCBI View Article : Google Scholar
2	Chantada GL, Qaddoumi I, Canturk S, Khetan V, Ma Z, Kimani K, Yeniad B, Sultan I, Sitorus RS, Tacyildiz N, et al: Strategies to manage retinoblastoma in developing countries. Pediatr Blood Cancer. 56:341–348. 2011.PubMed/NCBI View Article : Google Scholar
3	Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, Sultan I, Kebudi R, Sharma T, Rodriguez-Galindo C, et al: Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 94:1432–1436. 2010.PubMed/NCBI View Article : Google Scholar
4	Errico A: Cancer therapy: Retinoblastoma - chemotherapy increases the risk of secondary cancer. Nat Rev Clin Oncol. 11(623)2014.PubMed/NCBI View Article : Google Scholar
5	Shields CL, Say EA, Pointdujour-Lim R, Cao C, Jabbour PM and Shields JA: Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy. J Fr Ophtalmol. 38:542–549. 2015.PubMed/NCBI View Article : Google Scholar
6	Rao AKDM, Rajkumar T and Mani S: Perspectives of long non-coding RNAs in cancer. Mol Biol Rep. 44:203–218. 2017.PubMed/NCBI View Article : Google Scholar
7	Li S, Wen D, Che S, Cui Z, Sun Y, Ren H and Hao J: Knockdown of long noncoding RNA 00152 (LINC00152) inhibits human retinoblastoma progression. OncoTargets Ther. 11:3215–3223. 2018.PubMed/NCBI View Article : Google Scholar
8	Yang L, Zhang L, Lu L and Wang Y: Long noncoding RNA SNHG16 sponges miR-182-5p and miR-128-3p to promote retinoblastoma cell migration and invasion by targeting LASP1. OncoTargets Ther. 12:8653–8662. 2019.PubMed/NCBI View Article : Google Scholar
9	Wu XZ, Cui HP, Lv HJ and Feng L: Knockdown of lncRNA PVT1 inhibits retinoblastoma progression by sponging miR-488-3p. Biomed Pharmacother. 112(108627)2019.PubMed/NCBI View Article : Google Scholar
10	Wang L, Wang C, Wu T and Sun F: Long non-coding RNA TP73-AS1 promotes TFAP2B-mediated proliferation, metastasis and invasion in retinoblastoma via decoying of miRNA-874-3p. J Cell Commun Signal. 14:193–205. 2020.PubMed/NCBI View Article : Google Scholar
11	Chang W, Wang Y, Li W and Geng Z: Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis. Clin Exp Pharmacol Physiol. 47:1067–1075. 2020.PubMed/NCBI View Article : Google Scholar
12	Zhou Z, Zhang S and Xiong Y: Long noncoding RNA MIAT promotes non-small cell lung cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cancer Cell Int. 20(348)2020.PubMed/NCBI View Article : Google Scholar
13	Li F, Li H, Li S, Lv B, Shi J, Yan H, Zhang H and He Y: Long Non-coding RNA MIAT mediates non-small cell lung cancer development through regulating the miR-128-3p/PELI3 Axis. Biochem Genet. 58:867–882. 2020.PubMed/NCBI View Article : Google Scholar
14	Zhang L, Ge S and Cao B: Long non-coding RNA MIAT promotes cervical cancer proliferation and migration. J Biochem. 168:183–190. 2020.PubMed/NCBI View Article : Google Scholar
15	Zhou S, Xu A, Song T, Gao F, Sun H and Kong X: lncRNA MIAT regulates cell growth, migration, and invasion through sponging miR-150-5p in ovarian cancer. Cancer Biother Radiopharm. 35:650–660. 2020.PubMed/NCBI View Article : Google Scholar
16	Liu Y, Peng H, Shen Y, Da R, Tian A and Guo X: Downregulation of long noncoding RNA myocardial infarction associated transcript suppresses cell proliferation, migration, invasion, and glycolysis by regulation of miR-488-3p/IGF1R pathway in colorectal cancer. Cancer Biother Radiopharm: Oct 21, 2020 (Epub ahead of print). doi: 10.1089/cbr.2020.3671.
17	Sha M, Lin M, Wang J, Ye J, Xu J, Xu N and Huang J: Long non-coding RNA MIAT promotes gastric cancer growth and metastasis through regulation of miR-141/DDX5 pathway. J Exp Clin Cancer Res. 37(58)2018.PubMed/NCBI View Article : Google Scholar
18	Lu TX and Rothenberg ME: MicroRNA. J Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
19	Liu Y, Li H, Liu Y and Zhu Z: MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells. Biomed Pharmacother. 105:805–812. 2018.PubMed/NCBI View Article : Google Scholar
20	Wang L, Yang D, Tian R and Zhang H: NEAT1 promotes retinoblastoma progression via modulating miR-124. J Cell Biochem. 120:15585–15593. 2019.PubMed/NCBI View Article : Google Scholar
21	Han N, Zuo L, Chen H, Zhang C, He P and Yan H: Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p. OncoTargets Ther. 12:3509–3517. 2019.PubMed/NCBI View Article : Google Scholar
22	Xu L, Li W, Shi Q, Wang M, Li H, Yang X and Zhang J: MicroRNA 936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway. Oncol Rep. 43:635–645. 2020.PubMed/NCBI View Article : Google Scholar
23	Wang S, Du S, Lv Y, Zhang F and Wang W: MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway. Cancer Manag Res. 11:3111–3123. 2019.PubMed/NCBI View Article : Google Scholar
24	Zhang S, Long J and Hu Y: Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. Biochem Biophys Res Commun. 526:396–403. 2020.PubMed/NCBI View Article : Google Scholar
25	Hu S, Ran Y, Chen W, Zhang Y and Xu Y: MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1. Oncol Rep. 38:1569–1578. 2017.PubMed/NCBI View Article : Google Scholar
26	Yan P, Liu J, Zhou R, Lin C, Wu K, Yang S, Yang S, Zhou J, Xu L, Wang H, et al: LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion. Oncogene. 39:5743–5755. 2020.PubMed/NCBI View Article : Google Scholar
27	Wang S, Qiu J, Wang L, Wu Z, Zhang X, Li Q and Jiang F: Long non-coding RNA LINC01207 promotes prostate cancer progression by downregulating microRNA-1972 and upregulating LIM and SH3 protein 1. IUBMB Life. 72:1960–1975. 2020.PubMed/NCBI View Article : Google Scholar
28	Sui Y, Zhang X, Yang H, Wei W and Wang M: MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1. Oncol Rep. 39:473–482. 2018.PubMed/NCBI View Article : Google Scholar
29	Song X, Jin Y, Yan M, Zhang Y and Chen B: MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma. Oncol Lett. 17:688–696. 2019.PubMed/NCBI View Article : Google Scholar
30	Liu W, Wang ZL, Wang C and Ai ZL: Long non-coding RNA MIAT promotes papillary thyroid cancer progression through upregulating LASP1. Cancer Cell Int. 19(194)2019.PubMed/NCBI View Article : Google Scholar
31	Wang JX, Yang Y and Li K: Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9. J Cell Physiol. 233:6986–6995. 2018.PubMed/NCBI View Article : Google Scholar
32	Shang W, Yang Y, Zhang J and Wu Q: Long noncoding RNA BDNF-AS is a potential biomarker and regulates cancer development in human retinoblastoma. Biochem Biophys Res Commun. 497:1142–1148. 2018.PubMed/NCBI View Article : Google Scholar
33	Yan G, Su Y, Ma Z, Yu L and Chen N: Long Noncoding RNA LINC00202 promotes tumor progression by sponging miR-3619-5p in retinoblastoma. Cell Struct Funct. 44:51–60. 2019.PubMed/NCBI View Article : Google Scholar
34	Hu C, Liu S, Han M, Wang Y and Xu C: Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis. Biomed Pharmacother. 107:547–554. 2018.PubMed/NCBI View Article : Google Scholar
35	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
36	Du Z, Sun T, Hacisuleyman E, Fei T, Wang X, Brown M, Rinn JL, Lee MG, Chen Y, Kantoff PW, et al: Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 7(10982)2016.PubMed/NCBI View Article : Google Scholar
37	Hao F, Mou Y, Zhang L, Wang S and Yang Y: LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma. Biosci Rep. 38(38)2018.PubMed/NCBI View Article : Google Scholar
38	Zhao J, Yang T, Ji J, Zhao F, Li C and Han X: RHPN1-AS1 promotes cell proliferation and migration via miR-665/Akt3 in ovarian cancer. Cancer Gene Ther. 28:33–41. 2021.PubMed/NCBI View Article : Google Scholar
39	Ouyang S, Zhou X, Chen Z, Wang M, Zheng X and Xie M: LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int. 19(72)2019.PubMed/NCBI View Article : Google Scholar
40	Wu KZ, Zhang CD, Zhang C, Pei JP and Dai DQ: miR-665 suppresses the epithelial-mesenchymal transition and progression of gastric cancer by targeting CRIM1. Cancer Manag Res. 12:3489–3501. 2020.PubMed/NCBI View Article : Google Scholar
41	Orth MF, Cazes A, Butt E and Grunewald TG: An update on the LIM and SH3 domain protein 1 (LASP1): A versatile structural, signaling, and biomarker protein. Oncotarget. 6:26–42. 2015.PubMed/NCBI View Article : Google Scholar
42	Li Z, Chen Y, Wang X, Zhang H, Zhang Y, Gao Y, Weng M, Wang L, Liang H, Li M, et al: LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway. Cancer Lett. 372:239–250. 2016.PubMed/NCBI View Article : Google Scholar
43	Zheng J, Wang F, Lu S and Wang X: LASP-1, regulated by miR-203, promotes tumor proliferation and aggressiveness in human non-small cell lung cancer. Exp Mol Pathol. 100:116–124. 2016.PubMed/NCBI View Article : Google Scholar
44	Zhao L, Wang H, Liu C, Liu Y, Wang X, Wang S, Sun X, Li J, Deng Y, Jiang Y, et al: Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut. 59:1226–1235. 2010.PubMed/NCBI View Article : Google Scholar
45	Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A and Butt E: Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer. 96:296–305. 2007.PubMed/NCBI View Article : Google Scholar
46	Liu W, Wang Z, Wang C and Ai Z: Long non-coding RNA MIAT promotes papillary thyroid cancer progression through upregulating LASP1. Cancer Cell Int. 19(194)2019.PubMed/NCBI View Article : Google Scholar